deanol has been researched along with Dyskinesia, Drug-Induced in 35 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 34 (97.14) | 18.7374 |
1990's | 1 (2.86) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hobi, V; Kocher, R; Linder, M; Studer, K | 1 |
Ananth, J; Yassa, R | 1 |
Jeste, DV; Wyatt, RJ | 1 |
Tegeler, J; Wöller, W | 1 |
Alphs, LD; Davis, JM | 1 |
Aldous, D; George, J; Pridmore, S | 1 |
Ansell, GB | 1 |
Carroll, BJ; Curtis, GC; Kokmen, E | 1 |
Chien, C; Jung, K; Ross-Townsend, A | 1 |
Casey, DE | 3 |
de Maximy, B; Ghenim, A; Lambert, PA; Wolff, P | 1 |
Beilstein, BA; Davis, KL; Hollister, LE; Rosekind, GR; Vento, AL | 1 |
Annable, L; Chouinard, G; de Montigny, C | 1 |
Bralower, M; Tarsy, D | 1 |
Gautier, J; Jus, A; Jus, K; Pires, P; Villeneuve, A; Villeneuve, C; Villeneuve, R | 1 |
Goldblatt, D; Karch, F; Kerzner, B; Morgan, JP; Penovich, P | 1 |
Lakke, JP; Lindeboom, SF | 1 |
Lee, JH; Simpson, GM; Voitashevsky, A; Young, MA | 1 |
Casey, DE; Denney, D | 1 |
Amsterdam, J; Mendels, J | 1 |
King, HA; Lonowski, DJ; Sterling, FE | 1 |
Fann, WE; Stafford, JR | 1 |
Casey, DE; McLean, P | 1 |
McCall, AL; Millington, WR; Wurtman, RJ | 1 |
Bockenheimer, S; Lucius, G | 1 |
Chang, S; Crayton, JW; Ericksen, SE; Klass, D; Smith, RC | 1 |
Chang, S; Davis, JM; Ericksen, SE; Smith, RC; Tamminga, CA | 1 |
Berger, PA; Davis, KL; Hollister, LE | 1 |
Ray, I | 1 |
Carpenter, AE; Crews, EL | 1 |
Mathew, P; Mehta, D; Mehta, S | 1 |
Haug, BA; Holzgraefe, M | 1 |
Cai, N | 1 |
5 review(s) available for deanol and Dyskinesia, Drug-Induced
Article | Year |
---|---|
Lithium carbonate in the treatment of movement disorders. A critical review.
Topics: Adult; Aged; Antipsychotic Agents; Clinical Trials as Topic; Deanol; Dopamine; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Huntington Disease; Lithium; Lithium Carbonate; Male; Middle Aged; Tourette Syndrome | 1980 |
Therapeutic strategies against tardive dyskinesia. Two decades of experience.
Topics: Antipsychotic Agents; Choline; Clinical Trials as Topic; Deanol; Dopamine Antagonists; Double-Blind Method; Dyskinesia, Drug-Induced; Humans; Parasympatholytics; Phosphatidylcholines; Physostigmine | 1982 |
Cholinergic treatments for tardive dyskinesia.
Topics: Acetylcholine; Antipsychotic Agents; Choline; Clinical Trials as Topic; Corpus Striatum; Deanol; Dopamine; Dyskinesia, Drug-Induced; Humans; Parasympathomimetics; Phosphatidylcholines; Physostigmine; Research Design; Substance Withdrawal Syndrome | 1983 |
The biochemical background to tardive dyskinesia.
Topics: Acetylcholine; Animals; Choline; Deanol; Dyskinesia, Drug-Induced; Humans; Phosphatidylcholines | 1981 |
Deanol in the management of involuntary movement disorders: a review.
Topics: Acetylcholine; Deanol; Dopamine; Dyskinesia, Drug-Induced; Ethanolamines; Female; Humans; Huntington Disease; Levodopa; Male; Middle Aged; Models, Neurological; Movement Disorders; Parkinson Disease; Physostigmine; Research Design; Time Factors | 1977 |
15 trial(s) available for deanol and Dyskinesia, Drug-Induced
Article | Year |
---|---|
Lithium carbonate in the treatment of movement disorders. A critical review.
Topics: Adult; Aged; Antipsychotic Agents; Clinical Trials as Topic; Deanol; Dopamine; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Huntington Disease; Lithium; Lithium Carbonate; Male; Middle Aged; Tourette Syndrome | 1980 |
Therapeutic strategies against tardive dyskinesia. Two decades of experience.
Topics: Antipsychotic Agents; Choline; Clinical Trials as Topic; Deanol; Dopamine Antagonists; Double-Blind Method; Dyskinesia, Drug-Induced; Humans; Parasympatholytics; Phosphatidylcholines; Physostigmine | 1982 |
Cholinergic treatments for tardive dyskinesia.
Topics: Acetylcholine; Antipsychotic Agents; Choline; Clinical Trials as Topic; Corpus Striatum; Deanol; Dopamine; Dyskinesia, Drug-Induced; Humans; Parasympathomimetics; Phosphatidylcholines; Physostigmine; Research Design; Substance Withdrawal Syndrome | 1983 |
Double blind controlled trial of deanol in tardive dyskinesia.
Topics: Aged; Deanol; Dose-Response Relationship, Drug; Double-Blind Method; Dyskinesia, Drug-Induced; Ethanolamines; Female; Humans; Male; Middle Aged | 1981 |
Efficacies of agents related to GABA, dopamine, and acetylcholine in the treatment of tardive dyskinesia [proceedings].
Topics: Acetylcholine; Clinical Trials as Topic; Deanol; Dopamine; Dyskinesia, Drug-Induced; Ethanolamines; Female; gamma-Aminobutyric Acid; Humans; Indoles; Male; Middle Aged; Piperazines; Valerates; Valproic Acid | 1978 |
Mood alterations during deanol therapy.
Topics: Affective Symptoms; Alcoholism; Clinical Trials as Topic; Deanol; Double-Blind Method; Dyskinesia, Drug-Induced; Emotions; Ethanolamines; Humans; Movement Disorders; Placebos | 1979 |
Ineffectiveness of deanol in tardive dyskinesia: a placebo controlled study.
Topics: Adult; Aged; Clinical Trials as Topic; Deanol; Double-Blind Method; Dyskinesia, Drug-Induced; Ethanolamines; Female; Humans; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Schizophrenia | 1979 |
Deanol acetamidobenzoate treatment in choreiform movement disorders.
Topics: Benztropine; Clinical Trials as Topic; Deanol; Double-Blind Method; Drug Evaluation; Dyskinesia, Drug-Induced; Ethanolamines; Humans; Huntington Disease; Male; Middle Aged; Physostigmine | 1977 |
Deanol, lithium and placebo in the treatment of tardive dyskinesia. A double-blind crossover study.
Topics: Adult; Clinical Trials as Topic; Deanol; Double-Blind Method; Drug Evaluation; Dyskinesia, Drug-Induced; Electrocardiography; Electroencephalography; Ethanolamines; Female; Humans; Lithium; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Schizophrenia | 1978 |
Double-blind evaluation of deanol in tardive dyskinesia.
Topics: Adult; Aged; Clinical Trials as Topic; Deanol; Double-Blind Method; Drug Evaluation; Dyskinesia, Drug-Induced; Ethanolamines; Female; Humans; Male; Middle Aged | 1978 |
Deanol and physostigmine in the treatment of L-dopa-induced dyskinesias.
Topics: Aged; Clinical Trials as Topic; Deanol; Double-Blind Method; Drug Evaluation; Dyskinesia, Drug-Induced; Ethanolamines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Physostigmine; Placebos | 1978 |
Deanol in the treatment of tardive dyskinesia.
Topics: Aged; Clinical Trials as Topic; Deanol; Double-Blind Method; Drug Evaluation; Dyskinesia, Drug-Induced; Ethanolamines; Female; Humans; Male; Middle Aged; Placebos | 1977 |
Pharmacological characterization of tardive dyskinesia.
Topics: Adult; Benztropine; Clinical Trials as Topic; Deanol; Dopamine; Droperidol; Dyskinesia, Drug-Induced; Humans; Levodopa; Male; Middle Aged; Parasympatholytics; Physostigmine; Placebos; Time Factors | 1977 |
[Deanol in tardive dyskinesia: a double-blind study (author's transl)].
Topics: Adult; Aged; Clinical Trials as Topic; Deanol; Dyskinesia, Drug-Induced; Ethanolamines; Female; Humans; Male; Middle Aged; Tranquilizing Agents | 1976 |
Cholinergic influences in tardive dyskinesia.
Topics: Acetylcholine; Administration, Oral; Basal Ganglia; Choline; Deanol; Dyskinesia, Drug-Induced; Ethanolamines; Humans; Hypnotics and Sedatives; Injections, Intravenous; Methohexital; Motor Activity; Neostigmine; Physostigmine; Placebos; Receptors, Dopamine | 1977 |
18 other study(ies) available for deanol and Dyskinesia, Drug-Induced
Article | Year |
---|---|
[Treatment with dimethylaminoethanol (deanol) in neuroleptic induced tardive dyskinesia].
Topics: Adult; Aged; Antipsychotic Agents; Deanol; Double-Blind Method; Dyskinesia, Drug-Induced; Ethanolamines; Female; Humans; Male; Middle Aged | 1980 |
[Therapeutic measures in tardive dyskinesia].
Topics: Age Factors; Amantadine; Antipsychotic Agents; Baclofen; Benzodiazepines; Bromocriptine; Deanol; Dihydroxyphenylalanine; Dyskinesia, Drug-Induced; Humans; Phosphatidylcholines; Schizophrenia; Valproic Acid | 1983 |
Paradoxical response to dopamine agonists in tardive dyskinesia.
Topics: Adrenergic alpha-Agonists; Adult; Amantadine; Apomorphine; Benztropine; Clozapine; Deanol; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Antagonism; Drug Tolerance; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Levodopa; Physostigmine; Receptors, Dopamine; Reserpine; Stimulation, Chemical; Thioridazine | 1977 |
Managing tardive dyskinesia.
Topics: Antipsychotic Agents; Choline; Deanol; Dyskinesia, Drug-Induced; Humans; Lithium; Receptors, Dopamine; Reserpine; Substance Withdrawal Syndrome | 1978 |
[Dimethylaminoethanol in the treatment of neuroleptic-induced tardive dyskinesia].
Topics: Aged; Antipsychotic Agents; Deanol; Dyskinesia, Drug-Induced; Ethanolamines; Female; Humans; Male; Middle Aged; Schizophrenia, Paranoid | 1978 |
Dimethylaminoethanol (deanol): effect on apomorphine-induced stereotypy and an animal model of tardive dyskinesia.
Topics: Animals; Apomorphine; Behavior; Deanol; Dyskinesia, Drug-Induced; Ethanolamines; Humans; Male; Models, Psychological; Motor Activity; Rats; Stereotyped Behavior | 1979 |
Treatment-resistant tardive dyskinesia: a new therapeutic approach.
Topics: Aminobutyrates; Baclofen; Deanol; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Ethanolamines; Female; Humans; Middle Aged | 1979 |
Electromyographic assessment of dimethylaminoethanol (deanol) in treatment of tardive dyskinesia.
Topics: Aged; Deanol; Dyskinesia, Drug-Induced; Electromyography; Ethanolamines; Female; Humans; Male; Middle Aged | 1979 |
Deanol acetamidobenzoate (Deaner) in tardive dyskinesia.
Topics: Choline; Cyproheptadine; Deanol; Drug Evaluation; Dyskinesia, Drug-Induced; Ethanolamines; Humans; Male; Methylphenidate; Syndrome; Tranquilizing Agents | 1977 |
Tardive dyskinesia in an adolescent.
Topics: Adolescent; Age Factors; Child; Child Behavior Disorders; Deanol; Diagnosis, Differential; Dyskinesia, Drug-Induced; Humans; Lithium; Male; Tranquilizing Agents | 1978 |
Deanol acetamidobenzoate inhibits the blood-brain barrier transport of choline.
Topics: Acetylcholine; Animals; Blood-Brain Barrier; Brain; Brain Chemistry; Choline; Deanol; Dyskinesia, Drug-Induced; Ethanolamines; Male; Rats | 1978 |
Electrophysiological (H-reflex) studies of patients with tardive dyskinesia.
Topics: Amphetamine; Apomorphine; Deanol; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Electrophysiology; H-Reflex; Humans; Motor Neurons; Muscles; Neurons, Afferent; Physostigmine; Receptors, Dopamine; Reflex, Monosynaptic; Schizophrenia | 1977 |
Deanol in tardive dyskinesia.
Topics: Acetylcholine; Choline; Deanol; Dyskinesia, Drug-Induced; Ethanolamines; Humans | 1977 |
Tardive dyskinesia treated with deanol acetamidobenzoate.
Topics: Aged; Deanol; Dyskinesia, Drug-Induced; Ethanolamines; Female; Humans | 1977 |
Lithium-induced aggravation of tardive dyskinesia.
Topics: Acute Disease; Bipolar Disorder; Deanol; Dyskinesia, Drug-Induced; Female; Humans; Lithium; Middle Aged | 1977 |
Failure of deanol in treating tardive dyskinesia.
Topics: Aged; Chronic Disease; Deanol; Dyskinesia, Drug-Induced; Ethanolamines; Female; Humans; Male | 1976 |
Orofacial and respiratory tardive dyskinesia: potential side effects of 2-dimethylaminoethanol (deanol)?
Topics: Deanol; Diagnosis, Differential; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Neurologic Examination; Respiratory Muscles; Substance Withdrawal Syndrome; Tremor | 1991 |
[Treatment of 37 cases of tardive dyskinesia by deanol].
Topics: Adolescent; Adult; Deanol; Dyskinesia, Drug-Induced; Ethanolamines; Female; Humans; Male; Middle Aged; Psychotic Disorders; Psychotropic Drugs | 1985 |